Sivik Global Healthcare’s Natera NTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,000
Closed -$3.25M 43
2024
Q2
$3.25M Sell
30,000
-5,000
-14% -$508K 1.17% 33
2024
Q1
$3.2M Buy
+35,000
New +$2.63M 0.75% 38
2022
Q2
Sell
-50,000
Closed -$2.03M 50
2022
Q1
$2.03M Buy
50,000
+25,000
+100% +$1.5M 0.84% 47
2021
Q4
$2.33M Buy
+25,000
New +$2.59M 1% 39
2021
Q1
Sell
-20,000
Closed -$1.99M 55
2020
Q4
$1.99M Buy
+20,000
New +$1.67M 0.81% 37

Other funds holding NTRA

Sivik Global Healthcare's NTRA Position: Q3 2024 in Review

Sivik Global Healthcare sold out of Natera (NTRA) in Q3 2024, closing a stake of 30,000 shares — an estimated $3.25M sold.

Sivik Global Healthcare first reported a position in NTRA in Q4 2020 and held it in 5 quarters. The position peaked at $3.25M in Q2 2024. 495 funds tracked by Wall St. Rank hold NTRA as of Q3 2024.

  • Sivik Global Healthcare reported no remaining Natera position as of Q3 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 30,000 Natera shares in Q3 2024, an estimated $3.25M.
  • Sivik Global Healthcare first reported a position in Natera in Q4 2020 and held it in 5 quarters.
  • Sivik Global Healthcare's Natera position peaked at $3.25M in Q2 2024.
  • 495 funds tracked by Wall St. Rank held Natera as of Q3 2024.

Based on Sivik Global Healthcare's 13F filing for Q3 2024, filed 6 Nov 2024.